908 related articles for article (PubMed ID: 13680124)
1. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.
Delmeire D; Flamez D; Hinke SA; Cali JJ; Pipeleers D; Schuit F
Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124
[TBL] [Abstract][Full Text] [Related]
2. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
[TBL] [Abstract][Full Text] [Related]
3. The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release.
Dillon JS; Lu M; Bowen S; Homan LL
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):182-9. PubMed ID: 15789279
[TBL] [Abstract][Full Text] [Related]
4. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
5. Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells.
Roger B; Papin J; Vacher P; Raoux M; Mulot A; Dubois M; Kerr-Conte J; Voy BH; Pattou F; Charpentier G; Jonas JC; Moustaïd-Moussa N; Lang J
Diabetologia; 2011 Feb; 54(2):390-402. PubMed ID: 21046358
[TBL] [Abstract][Full Text] [Related]
6. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
Laychock SG
Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
[TBL] [Abstract][Full Text] [Related]
7. Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction.
Fehmann HC; Bode HP; Ebert T; Karl A; Göke B
Horm Metab Res; 1997 Nov; 29(11):572-6. PubMed ID: 9479558
[TBL] [Abstract][Full Text] [Related]
8. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
9. Adaptive changes in insulin secretion by islets from neonatal rats raised on a high-carbohydrate formula.
Srinivasan M; Aalinkeel R; Song F; Lee B; Laychock SG; Patel MS
Am J Physiol Endocrinol Metab; 2000 Dec; 279(6):E1347-57. PubMed ID: 11093923
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity.
Yada T; Itoh K; Nakata M
Endocrinology; 1993 Oct; 133(4):1685-92. PubMed ID: 8404610
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
12. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway.
Jimenez-Feltstrom J; Lundquist I; Salehi A
Cell Tissue Res; 2005 Feb; 319(2):221-30. PubMed ID: 15558323
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
[TBL] [Abstract][Full Text] [Related]
14. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
Lawrence MC; Bhatt HS; Easom RA
Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells.
Moens K; Berger V; Ahn JM; Van Schravendijk C; Hruby VJ; Pipeleers D; Schuit F
Diabetes; 2002 Mar; 51(3):669-75. PubMed ID: 11872665
[TBL] [Abstract][Full Text] [Related]
16. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
Hashiguchi S; Yada T; Arima T
J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.
Wheeler MB; Lu M; Dillon JS; Leng XH; Chen C; Boyd AE
Endocrinology; 1993 Jul; 133(1):57-62. PubMed ID: 8391428
[TBL] [Abstract][Full Text] [Related]
18. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
[TBL] [Abstract][Full Text] [Related]
19. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
Delmeire D; Flamez D; Moens K; Hinke SA; Van Schravendijk C; Pipeleers D; Schuit F
Biochem Pharmacol; 2004 Jul; 68(1):33-9. PubMed ID: 15183115
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Gromada J; Brock B; Schmitz O; Rorsman P
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
